Evidence brief · printable

Cystic Fibrosis evidence brief

One page, every section sourced. Print it or bring it on your phone.

Print or save as PDF Fits on one A4 or Letter page.

Cystic Fibrosis: evidence brief

Open Source Medicine Foundation · page built 16 November 2026 · trial data searched 2026-11-16 · https://research.opensourcemed.info/briefs/cystic-fibrosis.html

Research information, not medical advice. Prepared to support a conversation with a clinician, not to choose a treatment.

Live version

Medicines with registered trials

Scale: trials listed for each medicine on the tracker's condition page, a snapshot of ClinicalTrials.gov. A trial means it is being studied, not that it works.

  • Mannitol 4 trials
  • IVA (see NCT05331183) 3 trials
  • Elubrixin (SB656933) 2 trials
  • ELX/TEZ/IVA 2 trials
  • EUR-1008 (APT-1008) 2 trials
  • FDL169 (see NCT03424252) 2 trials

Non-drug approaches tested

Scale: trial status on ClinicalTrials.gov (completed, results posted). Status is not a result.

  • Vitamin D 12 trials · 10 completed · 2 with results
  • Light and laser therapy (photobiomodulation) 2 trials · 1 completed · 2 with results
  • Wearables and monitoring devices 8 trials · 5 completed · 1 with results
  • Breathing and respiratory muscle training 6 trials · 5 completed · 1 with results
  • Education, coaching and self-management 17 trials · 13 completed · 0 with results
  • Physiotherapy and physical therapy 15 trials · 12 completed · 0 with results

Natural products (RepurpOS Moderate tier)

Scale: RepurpOS evidence tier, from linked trials and literature. Product quality and dose vary.

  • Probiotics
  • Omega-3 Fatty Acids
  • Creatine
  • Lactobacillus Reuteri
  • Synbiotics

Trials recruiting

Status as recorded on ClinicalTrials.gov when searched (2026-11-16); check the registry for current status and eligibility.

  • A Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis NCT06559150
  • A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of… NCT07720375
  • Dose Range Finding, Efficacy, and Safety Study of Nebulized CSL787 in Adults With… NCT07048262
  • Long-term Evaluation of the SIMEOX Device at Home in Non-cystic Fibrosis… NCT06487273
  • Exercise in Child Health NCT05359991
  • CF Wellness Program NCT07071324

What we don't know yet

Gaps in registered trials, from the evidence-gap map. A gap is not a recommendation.

  • Among 19 trials of mind-body and psychological approaches found, none measured inflammation and other biomarkers 30 trials of other approaches did
  • Among 17 trials of rehabilitation and therapy services found, none measured inflammation and other biomarkers 30 trials of other approaches did
  • Among 17 trials of cognitive training and education found, none measured inflammation and other biomarkers 30 trials of other approaches did
  • Exercise and physical activity: breathing and lung function 9 trials, no results posted yet
  • Rehabilitation and therapy services: physical function and exercise capacity 7 trials, no results posted yet
Sources: ClinicalTrials.gov (trials, status, posted results); RepurpOS natural-product tiers (registry trials, PubMed, reference databases); OSMF biomarker atlas where available; OSMF non-drug evidence map (202 non-drug trials for this condition). Lists are shortened; the live pages carry every entry with its source: evidence-gap map · RepurpOS · condition page. Counts change daily. Nothing here is a recommendation to start, stop or change any treatment.